HEMOGLOBIN BETA THALASSEMIA DISEASE

Clinical trials for HEMOGLOBIN BETA THALASSEMIA DISEASE explained in plain language.

Never miss a new study

Get alerted when new HEMOGLOBIN BETA THALASSEMIA DISEASE trials appear

Sign up with your email to follow new studies for HEMOGLOBIN BETA THALASSEMIA DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human test of new sickle cell pill begins

Disease control Recruiting now

This is an early safety study to see if a pill called fostamatinib is safe and tolerable for adults with stable sickle cell disease. Up to 25 participants will take the drug at home for 6 weeks, with visits every 2 weeks to check for side effects. The main goal is to find a safe …

Matched conditions: HEMOGLOBIN BETA THALASSEMIA DISEASE

Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

HEMOGLOBIN BETA THALASSEMIA DISEASE

Get alerted when new HEMOGLOBIN BETA THALASSEMIA DISEASE trials appear

First human test of new sickle cell pill begins